ArticleCancer prevention research (Philadelphia, Pa.)2012

The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway.

M Carla Cabrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.